Mark Scott

1.2k total citations
27 papers, 922 citations indexed

About

Mark Scott is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Mark Scott has authored 27 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Mark Scott's work include Prostate Cancer Treatment and Research (6 papers), Cerebral Venous Sinus Thrombosis (5 papers) and Hormonal and reproductive studies (4 papers). Mark Scott is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Cerebral Venous Sinus Thrombosis (5 papers) and Hormonal and reproductive studies (4 papers). Mark Scott collaborates with scholars based in United States, Australia and India. Mark Scott's co-authors include Michael J. O’Connell, Charles G. Moertel, Bruce M. Boman, Robert J. Spencer, Leonard L. Gunderson, Robert W. Beart, Louis H. Weiland, Muriel I. Kaiser‐Kupfer, Marshall M. Parks and J. Fielding Hejtmancik and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Radiology.

In The Last Decade

Mark Scott

26 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Scott United States 15 383 342 262 221 143 27 922
Yeong Wook Song South Korea 19 87 0.2× 138 0.4× 201 0.8× 87 0.4× 81 0.6× 44 921
N. Stafford United Kingdom 15 134 0.3× 199 0.6× 250 1.0× 233 1.1× 56 0.4× 44 716
Constanze H. Kubisch Germany 15 188 0.5× 349 1.0× 197 0.8× 154 0.7× 50 0.3× 20 778
Felix W.M. de Rooij Netherlands 18 219 0.6× 334 1.0× 253 1.0× 134 0.6× 151 1.1× 44 951
Makio Kawakami Japan 16 122 0.3× 216 0.6× 212 0.8× 212 1.0× 18 0.1× 48 784
Sanai Noguchi Japan 15 106 0.3× 228 0.7× 110 0.4× 202 0.9× 46 0.3× 32 710
Menachem Laufer Israel 17 522 1.4× 488 1.4× 268 1.0× 229 1.0× 56 0.4× 51 1.1k
T. P. U. Wustrow Germany 13 467 1.2× 521 1.5× 111 0.4× 419 1.9× 41 0.3× 59 1.2k
Masato Kitazawa Japan 13 104 0.3× 132 0.4× 284 1.1× 163 0.7× 14 0.1× 69 689

Countries citing papers authored by Mark Scott

Since Specialization
Citations

This map shows the geographic impact of Mark Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Scott more than expected).

Fields of papers citing papers by Mark Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Scott. The network helps show where Mark Scott may publish in the future.

Co-authorship network of co-authors of Mark Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Scott. A scholar is included among the top collaborators of Mark Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Scott. Mark Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scott, Mark, et al.. (2001). Carotid artery ectasia coexistent with primary open angle glaucoma. Clinical and Experimental Ophthalmology. 29(1). 44–46. 2 indexed citations
2.
Scott, Mark, et al.. (2000). Comparison of orbital colour Doppler findings with computed tomography angiography. Clinical and Experimental Ophthalmology. 28(3). 175–177. 1 indexed citations
3.
Ren, Zhaoxia, Anren Li, Radha Ayyagari, et al.. (2000). A 5-base insertion in the γC-crystallin gene is associated with autosomal dominant variable zonular pulverulent cataract. Human Genetics. 106(5). 531–537. 77 indexed citations
4.
Gillies, W. E., et al.. (1999). Comparison of colour Doppler imaging of orbital vessels in elderly compared with young adult patients. Australian and New Zealand Journal of Ophthalmology. 27(3-4). 173–175. 11 indexed citations
5.
Scott, Mark & James Porter. (1997). Extraperitoneal bladder rupture: pitfall in CT cystography [clinical-conference].. American Journal of Roentgenology. 168(5). 1232–1232. 6 indexed citations
6.
Scott, Mark, et al.. (1994). Tortuosity of the retinal vessels in Aarskog syndrome (faciogenital dysplasia). Ophthalmic Genetics. 15(1). 37–40. 6 indexed citations
7.
Scott, Mark, J Richard, & Bradley K. Farris. (1994). Ankyloblepharon Filiforme Adnatum Associated With Infantile Glaucoma and Iridogoniodysgenesis. Journal of Pediatric Ophthalmology & Strabismus. 31(2). 93–95. 17 indexed citations
8.
Scott, Mark, et al.. (1994). Autosomal Dominant Congenital Cataract. Ophthalmology. 101(5). 866–871. 90 indexed citations
9.
Bouzas, Evrydiki A., George Mastorakos, Theodore C. Friedman, et al.. (1993). Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation.. PubMed. 34(13). 3497–500. 11 indexed citations
10.
Soloway, Mark S., Joseph A. Smith, Gerald W. Chodak, et al.. (1991). Zoladex versus orchiectomy in treatmentof advanced prostate cancer: a randomized trial. Urology. 37(1). 46–51. 53 indexed citations
11.
Citrin, Dennis L., et al.. (1991). A comparison of Zoladex® and DES in the treatment of advanced prostate cancer: Results of a randomized, multicenter trial. The Prostate. 18(2). 139–146. 28 indexed citations
12.
Kreis, Willi, Frederick R. Ahmann, Martin Lesser, et al.. (1990). Predictive initial parameters for response of stage D prostate cancer to treatment with the luteinizing hormone-releasing hormone agonist goserelin.. Journal of Clinical Oncology. 8(5). 870–874. 19 indexed citations
13.
Ahmann, Frederick R., et al.. (1988). Oestrogen Pre‐treatment Abolishes Luteinising Hormone‐Releasing Hormone Testosterone Stimulation. British Journal of Urology. 62(4). 352–354. 16 indexed citations
14.
Ahmann, Frederick R., Dennis L. Citrin, Patrick Guinan, et al.. (1987). Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer.. Journal of Clinical Oncology. 5(6). 912–917. 51 indexed citations
15.
O’Connell, Michael J., Allan J. Schutt, Charles G. Moertel, et al.. (1987). A Randomized Clinical Trial of Combination Chemotherapy in Advanced Colorectal Cancer. American Journal of Clinical Oncology. 10(4). 320–324. 3 indexed citations
16.
Bundy, Albert L., et al.. (1985). Delayed and occult splenic rupture. Computerized Radiology. 9(5). 299–305. 5 indexed citations
17.
Boman, Bruce M., Charles G. Moertel, Michael J. O’Connell, et al.. (1984). Carcinoma of the anal canal, a clinical and pathologic study of 188 cases. Cancer. 54(1). 114–125. 289 indexed citations
18.
Hazel, Guy A. Van, Mark Scott, & Robert T. Eagan. (1983). The effect of CNS metastases on the survival of patients with small cell cancer of the lung. Cancer. 51(5). 933–937. 56 indexed citations
19.
Josepovitz, C, et al.. (1982). Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations.. Journal of Pharmacology and Experimental Therapeutics. 223(2). 314–321. 82 indexed citations
20.
Scott, Mark, et al.. (1981). Computerized tomography in the diagnosis of abdominal aortic aneurysms.. PubMed. 153(2). 229–32. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026